BioNTech SE (BNTXN) Stock Statistics & Valuation Metrics
Total Valuation
BioNTech SE has a market cap or net worth of MXN 416.09B. The enterprise value is MXN 6.84B.
- Market Cap
- MXN 416.09B
- Enterprise Value
- MXN 6.84B
Share Statistics
BioNTech SE has 251,204,360 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 251,204,360
- Owned by Insiders
- 16.14%
- Owned by Institutions
- 1.04%
Financial Efficiency
BioNTech SE’s return on equity (ROE) is -0.06 and return on invested capital (ROIC) is -3.14%.
- Return on Equity (ROE)
- -0.06
- Return on Assets (ROA)
- -0.05
- Return on Invested Capital (ROIC)
- -3.14%
- Return on Capital Employed (ROCE)
- -0.03
- Revenue Per Employee
- 353.10K
- Profits Per Employee
- -139.78K
- Employee Count
- 7,807
- Asset Turnover
- 0.13
- Inventory Turnover
- 5.57
Valuation Ratios
The current PE Ratio of BioNTech SE is -11.50. BioNTech SE’s PEG ratio is 0.12.
- PE Ratio
- -11.50
- PS Ratio
- 7.37
- PB Ratio
- 1.11
- Price to FCF
- 37.47
- Price to Operating Cash Flow
- 26.62
- PEG Ratio
- 0.12
Income Statement
In the last 12 months, BioNTech SE had revenue of 2.76B and earned -1.09B in profits. Earnings per share was -4.51.
- Revenue
- 2.76B
- Gross Profit
- 2.14B
- Operating Income
- -623.87M
- Pretax Income
- -1.01B
- Net Income
- -1.09B
- EBITDA
- -628.00M
- Earnings Per Share (EPS)
- -4.51
Cash Flow
In the last 12 months, operating cash flow was 736.83M and capital expenditures -218.49M, giving a free cash flow of 518.34M billion.
- Operating Cash Flow
- 736.83M
- Free Cash Flow
- 518.34M
- Free Cash Flow per Share
- 2.05
Dividends & Yields
BioNTech SE pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 2.67%
- Earnings Yield
- -8.64%
Stock Price Statistics
- Beta
- 0.52
- 52-Week Price Change
- -12.31%
- 50-Day Moving Average
- 1723.73
- 200-Day Moving Average
- 1688.63
- Relative Strength Index (RSI)
- 64.73
- Average Volume (3m)
- 497
Important Dates
BioNTech SE upcoming earnings date is Nov 03, 2026, Before Open (Not Confirmed).
- Last Earnings Date
- Aug 04, 2026
- Next Earnings Date
- Nov 03, 2026
- Ex-Dividend Date
- ―
Financial Position
BioNTech SE as a current ratio of 7.54, with Debt / Equity ratio of 1.39%
- Current Ratio
- 7.54
- Quick Ratio
- 7.49
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 11.79
- Interest Coverage Ratio
- -45.74
Taxes
In the past 12 months, BioNTech SE has paid 81.93M in taxes.
- Income Tax
- 81.93M
- Effective Tax Rate
- -0.08
Enterprise Valuation
BioNTech SE EV to EBITDA ratio is -12.03, with an EV/FCF ratio of 19.34.
- EV to Sales
- 3.80
- EV to EBITDA
- -12.03
- EV to Free Cash Flow
- 19.34
- EV to Operating Cash Flow
- 13.62
Balance Sheet
BioNTech SE has MXN 9.74B in cash and marketable securities with MXN 315.97M in debt, giving a net cash position of MXN 9.42B billion.
- Cash & Marketable Securities
- MXN 9.74B
- Total Debt
- MXN 315.97M
- Net Cash
- MXN 9.42B
- Net Cash Per Share
- MXN 37.50
- Tangible Book Value Per Share
- MXN 62.98
Margins
Gross margin is 68.95%, with operating margin of -64.63%, and net profit margin of -64.25%.
- Gross Margin
- 68.95%
- Operating Margin
- -64.63%
- Pretax Margin
- -62.15%
- Net Profit Margin
- -64.25%
- EBITDA Margin
- -31.64%
- EBIT Margin
- -57.35%
Analyst Forecast
The average price target for BioNTech SE is MXN 2,311.92, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- MXN 2,311.92
- Price Target Upside
- 35.20% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 15
- Revenue Growth Forecast
- -6.76%
- EPS Growth Forecast
- -327.30%
Scores
- Smart Score
- 7
- AI Score
- ―